News
Barchart on MSN1mon
Vertex Pharmaceuticals Stock: Is VRTX Outperforming the Healthcare Sector?With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston ...
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback